BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13034159)

  • 1. [Practical experiences with miroton in therapy of cardiovascular diseases].
    STOHR W
    Hippokrates; 1952 Dec; 23(23):676-8. PubMed ID: 13034159
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experiences in the treatment of heart insufficiency with miroton].
    JANKE B
    Medizinische; 1955 Jun; 23():852-3. PubMed ID: 13244146
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with the cardio-sedative Seda-Miroton].
    Baldauf D
    Ther Ggw; 1969 May; 108(5):751 passim. PubMed ID: 5376946
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with an intravenously administered Crataeugus preparation].
    VON LOEWENSTEIN O
    Med Monatsschr; 1956 Jan; 10(1):26-7. PubMed ID: 13296853
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with the purified glycoside convallatoxin].
    WEISE H; ESSER H
    Med Klin; 1956 Mar; 51(11):432-3. PubMed ID: 13308774
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic use of crataegus in cardiovascular diseases].
    HERFORT H; LIERTZER V
    Wien Med Wochenschr; 1952 Jul; 102(29/30):580-2. PubMed ID: 12995624
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of medicinal plants in cardiovascular diseases].
    SEEL H
    Hippokrates; 1956 Jan; 27(2):42-5. PubMed ID: 13331344
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hypertension heart disease].
    BUCHSEL HW
    Ther Ggw; 1956 Jan; 95(1):29. PubMed ID: 13299287
    [No Abstract]   [Full Text] [Related]  

  • 9. [Follow-up report on miroton].
    BEYER W
    Hippokrates; 1959 Aug; 30():601-3. PubMed ID: 13800307
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with a new cardiac sedative (Seda-Miroton)].
    Klein HG
    Med Welt; 1966 Jul; 30():1592-4. PubMed ID: 5927501
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of heart disease in aged by miroton].
    KOTSOVSKY D
    Ther Ggw; 1955 Feb; 94(2):62. PubMed ID: 14373648
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of circulatory insufficiency with corglicone].
    BADALIAN GO
    Sov Med; 1958 Feb; 22(2):44-8. PubMed ID: 13556254
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic use of crataegus, a result of modern botanic pharmacology].
    MEYER E
    Munch Med Wochenschr; 1952 Jun; 94(24):1225-8. PubMed ID: 12982796
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy with Cor-Vel liquid in pre-digitalization].
    Chirstl G
    Z Allgemeinmed; 1973 Jul; 49(19):938-9. PubMed ID: 4737972
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of circulatory insufficiency with corglycon].
    RAKHIMBAEV KhKh
    Klin Med (Mosk); 1955 Jan; 33(1):85-6. PubMed ID: 14368835
    [No Abstract]   [Full Text] [Related]  

  • 16. [REMEDIUM CARDINALE. 5. MIROTON IN THE FORMULARY].
    SCHELLBERG E
    Hippokrates; 1963 Sep; 34():697-702. PubMed ID: 14048891
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indications for Crataegus therapy].
    STORCH H
    Med Klin; 1954 Aug; 49(34):1331-4. PubMed ID: 13203011
    [No Abstract]   [Full Text] [Related]  

  • 18. [Spring adonis (Adonis vernalis L.)].
    Sorokina AA
    Med Sestra; 1989 Sep; 48(9):43-5. PubMed ID: 2593790
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical contribution to the evaluation of cardiac efficiency by esbericard].
    ACKERMANN J
    Dtsch Med J; 1958 Feb; 9(2):68-70. PubMed ID: 13512101
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of cardiovascular disorders with cardisetten].
    FASSLER V
    Hippokrates; 1956 Jan; 27(2):60-2. PubMed ID: 13331349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.